Diacerein 1% ointment
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Diacerein 1% ointment, covering 2019-10-21 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS) [Phase 2, Phase 3]